People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tilray, Inc. | — | Other | Series C | $50.4M | $863.6M | 2018 |
| Privateer Holdings, Inc. | — | Other | Series B | $26.5M | $130.2M | 2014 |
| Stork Therapeutics, Inc. | — | Biotechnology | Seed | $1.3M | $4.2M | 2025 |
Brendan Kennedy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brendan Kennedy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Auerbach | 2 | 2 |
| Michael Blue | 1 | 4 |
| Christian Groh | 1 | 3 |
| Jeff Wechsler | 1 | 1 |
| Gregg Fine | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.